Search results
401 results found
Genome UK: new four nations commitments to priority actionsBlogNew commitments for UK-wide implementation of genomics have been announced that aim to accelerate research and drive healthcare innovation.
NHS reform plans: prevention, personalisation and personal responsibilityBlog The Rt Hon Sajid Javid announced his vision for reform of the NHS, outlined in a speech at the Royal College of Physicians and writing in the Daily Telegraph.
Further pieces found in the puzzle of severe COVID-19BlogA new study has provided further details on the genetic causes contributing to severe COVID-19.
Innovative regulation: keeping pace with genomics and software devicesBlogMHRA proposals on software and genetic testing devices are some of the most innovative and exciting developments set out for consultation.
Host genomics and COVID-19: where are we now?BlogCOVID-19 can have severe effects on even apparently low-risk individuals, and it has become clear that host factors affecting the risk of infection and disease progression include genomics.
COPI notices extended until March 2022BlogThe quiet extension by the UK Government of measures for lawful processing of confidential patient information for COVID-19 purposes is likely to have been welcomed by researchers.
Economies of scale: Genetically-targeted therapiesBlogThe genomics revolution has given us an exceptional understanding of what genes do, how they are expressed (turned on or off), and what happens when they don’t work as they should.
What does ‘good governance’ look like for genome editing?BlogPHG Policy Analyst, Tanya Brigden, usefully summarises the recommendations for the WHO's considerations towards genome editing
Expanding the public and patient role in medical regulationBlogA recent consultation by the UK Medicines and Healthcare products Regulatory Agency (MHRA) indicates a welcome new direction for public and patient involvement (PPI).
Making the UK a science superpower – will policy moves pay off for health?BlogThe recent and abrupt change in Secretary of State for Health for the UK has overshadowed some very significant policy developments over the last week.